Document is current
Any future updates will be listed below
-
Authors
Islampanah, Muhammad
Karami, Shaghayegh
Salehi, Sadaf
Akbari, Abolfazl
Noradini, Ali
Tafazolimoghadam, Armin
Yousefi, Shayan
Pirzad, Samira
- License Information
-
More Information
Article History
Received: 25 April 2025
Accepted: 5 February 2026
First Online: 21 February 2026
Declarations
:
: N/A.
: N/A.
: Veverimer effectively treats metabolic acidosis in chronic kidney disease, while also having similar side effects as the placebo group.
: The authors declare no competing interests.
